Annual Drug Patent Expirations for TREANDA
Treanda is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for TREANDA.
This drug has seventeen patent family members in eleven countries.
The generic ingredient in TREANDA is bendamustine hydrochloride. One supplier is listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com